Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
acute lymphoblastic leukemia
Pharma
Amgen's Blincyto proves its worth in pediatric leukemia study
The drug, along with chemotherapy, kept 96% of B-cell acute lymphoblastic leukemia patients alive and disease-free at the three-year mark.
Zoey Becker
Dec 9, 2024 11:43am
FDA approves Shorla's oral liquid version of Novartis' Gleevec
Nov 26, 2024 11:18am
For 2nd time in three months, Syndax wins FDA nod for a new drug
Nov 18, 2024 11:09am
Takeda's Iclusig wins first-line FDA nod to treat Ph+ALL
Mar 19, 2024 3:22pm
Takeda's Iclusig tops Novartis' Gleevec decisively in Ph+ALL
Feb 14, 2023 5:00pm
ASH: Amgen's Blincyto looks to establish new leukemia standard
Dec 13, 2022 10:00am
